NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, NEW ZEALAND, JAPAN, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, RUSSIA, BELARUS OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES. PLEASE REFER TO "IMPORTANT INFORMATION" AT THE END OF THE PRESS RELEASE. STOCKHOLM, June 13, 2022 /PRNewswire/ Mentice AB ("Mentice" or the "Company") hereby announces intention to carry out a directed new issue of shares of approximately SEK 60 million directed to Swedish and international institutional investors (the "Directed New Share Issue"). The Directed New Share Issue will be carried out to, among other things, finance the acquisition of all assets relating to the software solution Ankyras from the Spanish company Galgo Medical S.L. (the "Acquisition") which the Company announ
/PRNewswire/ Mentice AB ("Mentice" or the "Company") hereby announces intention to carry out a directed new issue of shares of approximately SEK 60 million.
/PRNewswire/ Mentice AB ("Mentice" or the "Company") hereby announces intention to carry out a directed new issue of shares of approximately SEK 60 million.